Gyre Therapeutics Inc. (GYRE) — Working Capital to Net Assets Ratio
Gyre Therapeutics Inc. (GYRE) has a Working Capital to Net Assets ratio of 60.2% as of September 2025. Working capital of $82.66 Million (current assets of $98.58 Million minus current liabilities of $15.91 Million) is measured against net assets of $137.41 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Gyre Therapeutics Inc. balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Gyre Therapeutics Inc. Working Capital to Net Assets (2004–2024)
This chart shows how Gyre Therapeutics Inc.'s Working Capital to Net Assets ratio has evolved across 21 annual periods from 2004 to 2024. As of September 2025, the ratio stands at 60.2%, reflecting working capital of $82.66 Million against net assets of $137.41 Million USD. Check tangible equity quality of Gyre Therapeutics Inc. to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Gyre Therapeutics Inc. (2004–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Gyre Therapeutics Inc. from 2004 to 2024, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see GYRE stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 46.0% | $45.27 Million | $98.40 Million | $64.79 Million | $19.52 Million | ▼ -220.5 pp |
| 2023 | 266.5% | $37.17 Million | $13.95 Million | $57.22 Million | $20.05 Million | ▲ +214.7 pp |
| 2022 | 51.8% | $37.41 Million | $72.22 Million | $49.65 Million | $12.24 Million | ▼ -39.0 pp |
| 2021 | 90.8% | $37.31 Million | $41.09 Million | $51.48 Million | $14.16 Million | ▼ -3.5 pp |
| 2020 | 94.3% | $71.71 Million | $76.07 Million | $89.51 Million | $17.80 Million | ▼ -4.0 pp |
| 2019 | 98.3% | $67.17 Million | $68.34 Million | $96.07 Million | $28.90 Million | ▼ -1.1 pp |
| 2018 | 99.4% | $119.19 Million | $119.94 Million | $123.99 Million | $4.80 Million | ▲ +0.7 pp |
| 2017 | 98.7% | $30.37 Million | $30.77 Million | $39.11 Million | $8.74 Million | ▲ +1.9 pp |
| 2016 | 96.8% | $15.56 Million | $16.07 Million | $37.52 Million | $21.96 Million | ▼ -1.7 pp |
| 2015 | 98.5% | $30.94 Million | $31.43 Million | $68.70 Million | $37.76 Million | ▲ +2.0 pp |
| 2014 | 96.5% | $105.23 Million | $109.08 Million | $108.14 Million | $2.91 Million | ▼ -3.1 pp |
| 2013 | 99.6% | $134.07 Million | $134.61 Million | $145.05 Million | $10.98 Million | ▼ -0.7 pp |
| 2012 | 100.3% | $176.36 Million | $175.91 Million | $187.71 Million | $11.35 Million | ▲ +31.4 pp |
| 2011 | 68.9% | $120.08 Million | $174.29 Million | $198.69 Million | $78.61 Million | ▼ -61.1 pp |
| 2010 | 130.0% | $119.42 Million | $91.85 Million | $218.08 Million | $98.66 Million | ▼ -179.1 pp |
| 2009 | 309.1% | $213.27 Million | $68.99 Million | $314.43 Million | $101.16 Million | ▲ +172.9 pp |
| 2008 | 136.3% | $78.17 Million | $57.37 Million | $91.97 Million | $13.79 Million | ▼ -13.4 pp |
| 2007 | 149.7% | $77.22 Million | $51.58 Million | $92.41 Million | $15.20 Million | ▲ +42.1 pp |
| 2006 | 107.5% | $69.90 Million | $65.00 Million | $78.85 Million | $8.95 Million | ▲ +120.2 pp |
| 2005 | -12.6% | $20.53 Million | $-162.48 Million | $25.74 Million | $5.21 Million | ▲ +28.1 pp |
| 2004 | -40.7% | $50.08 Million | $-122.97 Million | $55.39 Million | $5.31 Million | — |